Olivia Antonello
Family · The Woodlands, TXNPI 1609121680
Payments from drug & device makers
Across 94 payments — averaging $20.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$284
- AbbVie$252
- Exact Sciences$190
- Lilly USA, LLC$187
- Pfizer$161
- Abbott$145
- plus $731 from 18 others
What the payments were for
- Food & beverage$1,948100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 10 | $284 |
| AbbVie | 15 | $252 |
| Exact Sciences | 10 | $190 |
| Lilly USA, LLC | 11 | $187 |
| Pfizer | 7 | $161 |
| Abbott | 5 | $145 |
| AstraZeneca | 7 | $109 |
| Amarin Pharma, Inc. | 5 | $102 |
| Astellas Pharma US Inc | 4 | $85 |
| Evoke Pharma, Inc. | 2 | $58 |
| Shield Therapeutics Inc | 3 | $50 |
| Ironwood Pharmaceuticals, Inc | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Johnson & Johnson | 1 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Inari Medical, Inc. | 1 | $20 |
| GSK | 1 | $20 |
| Novartis | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Wegovy$113
How this compares
$1,948 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 70 | $100,719 |
| XareltoRivaroxaban | 21 | $35,459 |
| MounjaroTirzepatide | 22 | $20,456 |
| EliquisApixaban | 18 | $19,326 |
| TrulicityDulaglutide | 11 | $18,529 |
| FarxigaDapagliflozin Propanediol | 11 | $12,052 |
| Tresiba Flextouch U-200Insulin Degludec | 19 | $11,664 |
| JanuviaSitagliptin Phosphate | 11 | $5,538 |
| Atorvastatin Calcium | 375 | $3,866 |
| Varenicline Tartrate | 15 | $2,485 |
| Gabapentin | 79 | $2,144 |
| Losartan Potassium | 190 | $2,081 |
| Fluticasone Propionate | 128 | $2,005 |
| Insulin Aspart FlexpenInsulin Aspart | 13 | $1,835 |
| Omeprazole | 112 | $1,607 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $284 | $100,71970 claims |
| Lilly USA, LLCMounjaro, Trulicity | $187 | $38,98533 claims |
| Johnson & JohnsonXarelto | $26 | $35,45921 claims |
| PfizerEliquis | $161 | $19,32618 claims |
| AstraZenecaFarxiga | $109 | $12,05211 claims |
| AbbVieSynthroid | $252 | $1,01024 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 15,456 family providers in Texas.
Other family in The Woodlands
- Maggie LavenderThe Woodlands$76K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.